Re:Cognition Health Achieves Global Clinical Site Assessment Recertification at its U.S. Clinics

Global Light Therapy Market Size Will Reach $802.7 Million by 2031, Growing at a CAGR of 4.4% -- Allied Market Research

Animal Rescue Corps partners with National Mill Dog Rescue to save more than 60 dogs from commercial breeders

BCEN Announces 2026 Distinguished Awards Honoring Top Board-Certified Emergency, Trauma, Transport and Burn Nurses

LiveOnNY Hosts Inaugural Luminaries & Legacies Celebration Honoring NYC Metro-Area Hospitals and Renowned Surgeon and Humanitarian Dr. Robert Montgomery

Thousands of attendees raise nearly $2 million for The Michael J. Fox Foundation at the 2026 Parkinson's Unity Walk

Healthcare Information Exchange Market worth $3.40 billion by 2031 | MarketsandMarkets™

AssureCare and Pillr Health Partner to Help Health Systems Tackle Specialty Pharmacy Costs

Purina Cat Chow Brings the Healing Power of Cats to College Campuses Across the Country

Norgine gibt die Marktzulassung der Europäischen Kommission für XOLREMDI® (Mavorixafor) bekannt, die erste zugelassene Behandlung für Patienten mit WHIM-Syndrom in der Europäischen Union

SnapCare and connectRN Join Forces to Provide Growth-Forward Workforce Solutions Powering Better Care

RED PHONE BOOTH HOSTS NATIONWIDE KENTUCKY DERBY WATCH PARTY ON MAY 2

GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Investigational Stem Cell Therapy for Hemophilia A

What If Food Was at the Center of How We Live? Introducing CERES Chatt Hills - The Country's First Culinary Centric Community

NanoMosaic to Showcase the FDA/CBER AMT Designated Analytics Platform at ASGCT 2026

Earflo Announces FDA Clearance and US Market Availability of Award-Winning Pediatric Ear Pressure Treatment

Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union

R3 Continuum Expands Clinical Leadership Team to Accelerate Growth and Market Impact

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3

China's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth

Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025

PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® - Early-Stage Invasive Breast Cancer Assay

Life Time's LT Pro 48 Pickleball Named Official Ball of Major League Pickleball; 2026 Season Kicks off in Dallas May 22

Energenesis Biomedical to Present Clinical Application of ENERGI-F703DFU for Diabetic Foot Ulcers at EWMA 2026

Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology

INTCO Medical Reports 2025 Results with Resilient Growth, Revenue Reaches Four-Year High as Industry Rebalances

Greywolf Therapeutics and Genomics Launch Strategic Relationship to Develop First‑in‑Class Treatments for Autoimmune Diseases

Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study

CONCEPT MEDICAL STELLT VORLÄUFIGE 3-JAHRES-DATEN ZU SIRONA AUF DEM CHARING CROSS SYMPOSIUM 2026 VOR